Bristol Myers Exceeds Profit Estimates With Strong Sales
30 Apr 2026 //
REUTERS
Analysts focus on 3 Programs in Big year for Bristol Myers
30 Apr 2026 //
ENDPOINTS
BMS, Pfizer Offer Eliquis Via Mark Cuban`s Cost Plus Drugs
24 Apr 2026 //
FIRSTWORD PHARMA
Atrium Therapeutics Nets $15M from BMS in Global CV Collaboration
23 Apr 2026 //
PR NEWSWIRE
BMS layoffs hits Lawrenceville hard, adding 200+ to cut count
20 Apr 2026 //
BIOSPACE
Oxford Biotherapeutics Collaborates With Bristol Myers Squibb
09 Apr 2026 //
GLOBENEWSWIRE
FDA Lifts Macrogenics Hold; Oxford And Bristol Myers Team Up
09 Apr 2026 //
ENDPOINTS
BMS Advances Equity in Multiple Myeloma Program at 10 Years
31 Mar 2026 //
BUSINESSWIRE
BMS Links Up With Faro To Use AI To Improve Trial Protocols
31 Mar 2026 //
FIERCE BIOTECH
Insitro & BMS Collaboration Expanded with Nomination of Targets
23 Mar 2026 //
BUSINESSWIRE
Bristol Myers Squibb Strengthens Ohcm Leadership With Camzyos
23 Mar 2026 //
PHARMIWEB
Bristol Myers Squibb To Report Results For First Quarter 2026
19 Mar 2026 //
BUSSINESSWIRE
BMS Brings Ashley Park Aboard Campaign Honoring Oncologists
18 Mar 2026 //
FIERCE PHARMA
FDA Expands Label For BMS` Sotyktu To Treat Psoriatic Arthritis
10 Mar 2026 //
FIERCE PHARMA
Bristol Myers Squibb Announces Dividend
02 Mar 2026 //
BUSINESSWIRE
Evinova Secures AI Deals with Astellas, AstraZeneca
24 Feb 2026 //
FIERCE BIOTECH
BMS, Catalent Further Whittle Workforces
23 Feb 2026 //
BIOSPACE
Bristol Myers Squibb Joins TD Cowen Health Care Conference
23 Feb 2026 //
BUSINESSWIRE
BMS And Evinova Pen Global Development Partnership
09 Feb 2026 //
FIERCE BIOTECH
Evinova, Bristol Myers Squibb Partner To Enhance Clinical
09 Feb 2026 //
BUSINESSWIRE
BMS Beats Again Despite Eliquis And Cobenfy Disappointments
05 Feb 2026 //
BIOSPACE
BMS Snags Top Neuro Researcher From Eisai—Chutes & Ladders
23 Jan 2026 //
FIERCE BIOTECH
PRI Files Amicus Brief in SCOTUS Medical Freedom Case
16 Jan 2026 //
PR NEWSWIRE
Bristol Myers CEO Pledges To `Cast A Broad Net` In Dealmaking
12 Jan 2026 //
FIERCE BIOTECH
Tempus Achieves Record Total Contract Value Exceeding $1.1 B
11 Jan 2026 //
BUSINESSWIRE
Bristol Myers Squibb at J.P. Morgan`s 44th Healthcare Conference
02 Jan 2026 //
BUSINESSWIRE
Bristol Myers Squibb To Release Q4 2025 Results On Feb 5, 2026
18 Dec 2025 //
BUSINESSWIRE
Bristol Myers Squibb Launches Ai-Powered `Mosaic` Hub In Mumbai
17 Dec 2025 //
INDPHARMAPOST
Harbour BioMed Signs Antibody Deal with Bristol Myers Squibb
16 Dec 2025 //
PR NEWSWIRE
Bristol Myers Squibb Announces Dividend Increase
10 Dec 2025 //
BUSINESSWIRE
Bristol Myers Squibb Continues ADEPT-2 Phase 3 Study In AD
03 Dec 2025 //
PHARMIWEB
BMS Joins Citi`s 2025 Global Healthcare Conference
26 Nov 2025 //
BUSINESSWIRE
Bristol Myers Squibb To Host Hematology-Focused Investor Event
24 Nov 2025 //
BUSINESSWIRE
Bristol Myers Squibb Reveals Accepted Amounts & Pricing Terms
18 Nov 2025 //
BUSINESSWIRE
Update On Phase 3 Librexia ACS Trial
15 Nov 2025 //
BUSINESSWIRE
Sarah Cannon & Bristol Myers Squibb Expand Collaboration
12 Nov 2025 //
BUSINESSWIRE
Bristol Myers Squibb Prices €5B Senior Unsecured Notes
10 Nov 2025 //
INDPHARMAPOST
BMS Builds A `World Of Gratitude` To Honor HCPs In New PSA
10 Nov 2025 //
FIERCE PHARMA
Bristol Myers Squibb Prices €5 Billion Of Senior Unsecured Notes
05 Nov 2025 //
BUSINESS WIRE
Bristol Myers Squibb Presents Cardiovascular Portfolio Data
03 Nov 2025 //
BUSINESSWIRE
BMS Announces Cash Tender Offers To Purchase Notes
03 Nov 2025 //
BUSINESSWIRE
Bristol Myers Squibb Posts Q3 2025 Revenues $12.2 Billion
02 Nov 2025 //
INDPHARMAPOST
Bristol Myers Squibb Unveils Q3 2025 Financial Results
30 Oct 2025 //
BUSINESSWIRE
Cobenfy Delivers OK Debut Year As BMS Works To Ease Nerves
30 Oct 2025 //
FIERCE PHARMA
Evotec Announces Preclinical Neuroscience Partnership with BMS
27 Oct 2025 //
PHARMIWEB
Insitro Extends Research Collab with BMS via ChemML Platform
14 Oct 2025 //
BUSINESSWIRE
Bristol Myers Squibb Highlights Oncology Innovations At ESMO 2025
14 Oct 2025 //
INDPHARMAPOST
Bristol Myers Squibb To Showcase Oncology Portfolio Progress
13 Oct 2025 //
BUSINESSWIRE
Bristol Myers Squibb launches Kopozgo (Mavacamten) in India
13 Oct 2025 //
EXPRESSPHARMA
BMS Launches Patient Connect, Expands Access to Sotyktu
30 Sep 2025 //
INDPHARMAPOST
BMS Expands Patient Connect Platform With Eliquis And Sotyktu
25 Sep 2025 //
BUSINESSWIRE
BMS Puts Discounted Sotyktu At The Center Of Next DTC Platform
25 Sep 2025 //
FIERCE PHARMA
BMS Will Charge Same Price In Uk As Its Does In Us For Cobenfy
22 Sep 2025 //
FIERCE PHARMA
Bristol Myers Squibb to Report Q3 2025 Results on Oct 30, 2025
19 Sep 2025 //
BUSINESSWIRE
Novo, BMS Layoffs Leave Over 500 Jobless in New Jersey
18 Sep 2025 //
BIOSPACE
6 Pharma Layoffs Could Eliminate Over 39,000 Jobs
18 Sep 2025 //
BIOSPACE
Bristol Myers Squibb Announces Dividend
17 Sep 2025 //
BUSINESSWIRE
NJ layoffs: Novo Nordisk dismisses 263, BMS cuts 282 workers
17 Sep 2025 //
FIERCE PHARMA
BMS Sells Majority Stake in Historic US-China Pharmaceutical JV
16 Sep 2025 //
FIERCE PHARMA
Novartis Falls in Another IRA Price Negotiation Loss for Pharma
12 Sep 2025 //
FIERCE PHARMA

Market Place
Sourcing Support